INNOCAN PHARMA Corp
INNPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,652 | -$315 | -$229 | -$48 |
| Dep. & Amort. | $11 | $9 | $10 | $6 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,595 | $23 | $95 | $252 |
| Change in WC | -$907 | $891 | $489 | $36 |
| Other Non-Cash | $967 | $78 | $3 | -$750 |
| Operating Cash Flow | $22 | $686 | $368 | -$504 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$1 | -$5 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$1 | $1 | $69 |
| Investing Cash Flow | -$4 | -$2 | -$4 | $65 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | -$4 | $636 | -$6 |
| Stock Issued | -$4 | $93 | $359 | -$123 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | $64 | $1 | $529 |
| Financing Cash Flow | -$12 | $153 | $996 | $400 |
| Forex Effect | -$5 | $53 | -$3 | -$10 |
| Net Chg. in Cash | -$7 | $890 | $1,357 | -$49 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,342 | $6,365 | $5,008 | $5,057 |
| End Cash | $7,335 | $7,255 | $6,365 | $5,008 |
| Free Cash Flow | $18 | $685 | $363 | -$508 |